Lloyds Banking Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-15,165
Closed -$776K 107
2014
Q3
$776K Buy
15,165
+4,788
+46% +$239K 0.21% 123
2014
Q2
$503K Sell
10,377
-1,086,877
-99% -$53.6M 0.12% 187
2014
Q1
$57M Buy
1,097,254
+302,338
+38% +$16.1M 0.51% 55
2013
Q4
$42.2M Buy
794,916
+79,265
+11% +$4.04M 0.38% 71
2013
Q3
$33.1M Buy
715,651
+76,155
+12% +$3.34M 0.34% 79
2013
Q2
$28.6M Buy
+639,496
New +$27.8M 0.3% 87

Other funds holding BMY

Lloyds Banking Group's BMY Position: Q4 2014 in Review

Lloyds Banking Group sold out of Bristol-Myers Squibb (BMY) in Q4 2014, closing a stake of 15,165 shares — an estimated $776K sold.

Lloyds Banking Group first reported a position in BMY in Q2 2013 and held it in 6 quarters. The position peaked at $57M in Q1 2014. 1,409 funds tracked by Wall St. Rank hold BMY as of Q4 2014.

  • Lloyds Banking Group reported no remaining Bristol-Myers Squibb position as of Q4 2014 after selling out during the quarter.
  • Lloyds Banking Group sold 15,165 Bristol-Myers Squibb shares in Q4 2014, an estimated $776K.
  • Lloyds Banking Group first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 6 quarters.
  • Lloyds Banking Group's Bristol-Myers Squibb position peaked at $57M in Q1 2014.
  • 1,409 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2014.

Based on Lloyds Banking Group's 13F filing for Q4 2014, filed 12 Feb 2015.